J.W. Cole Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

J.W. Cole Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$274K	Buy	+4,829	New	+$230K	﹤0.01%	1325

Other funds holding GNOM

SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

Evolution Wealth Management Fort Myers, Florida $170M AUM 19.89% 1-Year Est. Return

J.W. Cole Advisors's GNOM Position: Q2 2026 in Review

J.W. Cole Advisors opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q2 2026: 4,829 shares worth $274K. The stake represents ﹤0.01% of the portfolio and ranks #1325 among its holdings.

12 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

J.W. Cole Advisors held 4,829 shares of Global X Genomics & Biotechnology ETF worth $274K as of Q2 2026.
Global X Genomics & Biotechnology ETF was a new J.W. Cole Advisors position in Q2 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #1325 holding.
12 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.